IVFarma LLC Report issue

For profit Phase 3
Founded: Russian Federation (2014)

Organization Overview

First Clinical Trial
2015
NCT03857230
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

IVFarma LLC

Active Ingredients

Drugs in Phase 3 Trials (1)

follitropin alfa (Gonal-F) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infertility (Phase 3)

Infertility, Female (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1